Search results for: antinuclear antibody

Communications Line to the Top

Sherine Gabriel, MD | May 1, 2009

The Affiliate Society Council brings local concerns to the ACR leadership

Hard Work Behind the Scenes

Alfred E. Denio, MD | May 1, 2009

My first ACR board meeting gives an insider’s view

Know Your Labs

Peter H. Schur, MD | February 1, 2009

A review of state-of-the-art testing for SLE and connective tissue disease.

Opportunities Abound at Annual Meeting

From the College | July 1, 2008

The 2008 ACR/ARHP Annual Scientific Meeting will offer multiple opportunities for attendees to increase their knowledge of rheumatic diseases. New educational programs and returning favorites will give attendees multiple chances to enhance their education and make good use of their time at the meeting.

Myositis Mysteries

Kathleen M. Coyle, MD, Paul H. Plotz, MD, and Mark F. Gourley, MD | January 1, 2008

Why isn’t my myositis patient getting better?

Watch Those Eyes

Sirichai Pasadhika,MD and James T. Rosenbaum, MD | December 1, 2007

What you need to know about Uveitis in Rheumatic Diseases

State-of-the-Art Care for Your Practice

Jane Jerrard | June 1, 2007

Clinical updates from the ACR Symposium

Why I Still Like Being a Rheumatologist

Neal S. Birnbaum, MD | June 1, 2007

The rewards of practice outshine the lure of retirement

The Chimeric Self

J. Lee Nelson, MD, and Anne Stevens, MD, PhD | February 1, 2007

Michrochimerism research offers insights into several autoimmune conditions

Anti-Nuclear Antibodies & Nuclear Molecules in Systemic Lupus Erythematosus

Katie Robinson | September 6, 2024

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that primarily affects young women and causes a wide range of inflammatory manifestations. Its hallmark is the production of antibodies to components of the cell nucleus (anti-nuclear antibodies [ANAs]). …